ALS LIMITED — Capital/Financing Update 2018

Aug 6, 2018

==> picture [180 x 69] intentionally omitted <==

asx/media release

7 August 2018

ALS expands Life Sciences business with strategic acquisitions

ALS Limited (ASX Code: ALQ) today announced the completion of three separate strategic acquisitions totalling $18million in its Life Sciences business stream in Brazil, USA and Italy.

LABFOR Analises Laboratoriasis based in Sao Paulo, Brazil is a life sciences testing laboratory business offering veterinary, agrochemical and pharmaceutical testing services. The business employs over 35 staff and is expanding its presence in the burgeoning Brazilian human pharmaceutical market which is expected to reach a value of close to $30 billion dollars by 2021.

Based in Irvine, California in the United States, ALS also acquired Truesdail Laboratories which will increase the pharmaceutical, nutraceutical, environment and food testing capabilities of the USA Life Sciences business stream. Truesdail has operated in the sector for over 85 years and maintains a staff of 45 highly qualified technical professionals with extensive knowledge in Drug, Environment and Nutrition Testing and Consumer Plumbing Product Certification.

As further evidence of the strategic expansion of the Life Sciences division, ALS recently acquired the Italian based environmental and consultancy firm, FELSILAB. An important component of the hub and spoke model in Northern Italy, FELSILAB provides a range of testing services to local food growers, processors, distributors and retailers, as well as environmental analytical services and technical training.

ALS Managing Director and CEO Raj Naran commented “The acquisition of these three highly regarded businesses in the Food and Pharmaceutical sector across three different geographies demonstrates our commitment and confidence in achieving the strategic priorities outlined in our 2022 Strategic Plan. The goal of achieving a balanced portfolio through our Life Sciences and Industrial divisions and increasing our non-resource related earnings is well advanced by the addition each of these businesses and their highly skilled employees.”

-ENDS-

Further information:

Raj Naran Managing Director ALS Limited +61 (7) 3367 7900

About ALS Limited

ALS is a global Testing, Inspection & Certification business. The company's strategy is to broaden its exposure into new sectors and geographies where it can take a leadership position.